Holdings (Monthly)
Guide ↗
Franklin Genomic Advancements ETF
· Franklin Templeton ETF Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Guardant Health Inc | GH | Mar 2026 | 15,718 | $1.5M | 6.77% | EC |
| 2 | NATERA INC | NTRA | Mar 2026 | 7,131 | $1.4M | 6.65% | EC |
| 3 | Krystal Biotech Inc | KRYS | Mar 2026 | 4,418 | $1.1M | 5.32% | EC |
| 4 | United Therapeutics Corporation | UTHR | Mar 2026 | 1,680 | $996K | 4.64% | EC |
| 5 | Insmed Inc | INSM | Mar 2026 | 5,932 | $970K | 4.52% | EC |
| 6 | Bridgebio Pharma Inc | BBIO | Mar 2026 | 12,192 | $905K | 4.22% | EC |
| 7 | Ligand Pharmaceuticals Incorporated | LGND | Mar 2026 | 3,794 | $757K | 3.53% | EC |
| 8 | AstraZeneca PLC | AZN | Mar 2026 | 3,695 | $729K | 3.40% | EC |
| 9 | Adaptive Biotechnologies Corp | ADPT | Mar 2026 | 48,245 | $670K | 3.12% | EC |
| 10 | Vertex Pharmaceuticals Incorporated | VRTX | Mar 2026 | 1,435 | $641K | 2.99% | EC |
| 11 | Samsung Biologics Co Ltd | 207940 | Mar 2026 | 652 | $640K | 2.99% | EC |
| 12 | Medpace Holdings Inc. | MEDP | Mar 2026 | 1,327 | $637K | 2.97% | EC |
| 13 | Regeneron Pharmaceuticals, Inc. | REGN | Mar 2026 | 748 | $578K | 2.69% | EC |
| 14 | Corteva Inc | CTVA | Mar 2026 | 6,904 | $578K | 2.69% | EC |
| 15 | Alnylam Pharmaceuticals Inc. | ALNY | Mar 2026 | 1,687 | $558K | 2.60% | EC |
| 16 | Eli Lilly & Co. | LLY | Mar 2026 | 593 | $545K | 2.54% | EC |
| 17 | Ionis Pharmaceuticals, Inc. | IONS | Mar 2026 | 5,957 | $447K | 2.09% | EC |
| 18 | Tempus AI Inc. | TEM | Mar 2026 | 8,726 | $395K | 1.84% | EC |
| 19 | BioNTech SE | BNTX | Mar 2026 | 4,340 | $386K | 1.80% | EC |
| 20 | Neurocrine Biosciences Inc | NBIX | Mar 2026 | 2,693 | $355K | 1.65% | EC |
| 21 | Stoke Therapeutics Inc | STOK | Mar 2026 | 10,539 | $343K | 1.60% | EC |
| 22 | Twist Bioscience Corporation | TWST | Mar 2026 | 7,184 | $341K | 1.59% | EC |
| 23 | Argenx SE | ARGX | Mar 2026 | 459 | $328K | 1.53% | EC |
| 24 | PTC Therapeutics, Inc. | PTCT | Mar 2026 | 4,652 | $317K | 1.48% | EC |
| 25 | Travere Therapeutics Inc | TVTX | Mar 2026 | 10,129 | $301K | 1.40% | EC |
| 26 | Charles River Laboratories International, Inc. | CRL | Mar 2026 | 1,445 | $249K | 1.16% | EC |
| 27 | CRISPR Therapeutics AG | CRSP | Mar 2026 | 4,671 | $222K | 1.04% | EC |
| 28 | Repligen Corporation | RGEN | Mar 2026 | 1,866 | $220K | 1.03% | EC |
| 29 | Veracyte Inc | VCYT | Mar 2026 | 6,788 | $219K | 1.02% | EC |
| 30 | Praxis Precision Medicines Inc | PRAX | Mar 2026 | 667 | $215K | 1.00% | EC |
| 31 | GRAIL Inc | GRAL | Mar 2026 | 4,138 | $214K | 1.00% | EC |
| 32 | Sartorius AG | SRT3 | Mar 2026 | 841 | $205K | 0.96% | EP |
| 33 | Danaher Corporation | DHR | Mar 2026 | 1,050 | $199K | 0.93% | EC |
| 34 | Thermo Fisher Scientific Inc | TMO | Mar 2026 | 391 | $192K | 0.90% | EC |
| 35 | IQVIA Holdings Inc. | IQV | Mar 2026 | 1,005 | $171K | 0.80% | EC |
| 36 | BEAM THERAPEUTICS INC | BEAM | Mar 2026 | 7,036 | $168K | 0.78% | EC |
| 37 | Jazz Pharmaceuticals PLC | JAZZ | Mar 2026 | 841 | $159K | 0.74% | EC |
| 38 | Catalyst Pharmaceuticals Inc. | CPRX | Mar 2026 | 6,375 | $158K | 0.74% | EC |
| 39 | Cadence Design Systems, Inc. | CDNS | Mar 2026 | 545 | $151K | 0.71% | EC |
| 40 | Agilent Technologies Inc. | A | Mar 2026 | 1,136 | $129K | 0.60% | EC |
| 41 | Caredx Inc | CDNA | Mar 2026 | 7,429 | $129K | 0.60% | EC |
| 42 | QIAGEN NV | QGEN | Mar 2026 | 3,175 | $127K | 0.59% | EC |
| 43 | AnaptysBio Inc. | ANAB | Mar 2026 | 2,041 | $113K | 0.53% | EC |
| 44 | SAMSUNG EPIS HOLDINGS CO LTD | 0126Z0 | Mar 2026 | 350 | $113K | 0.53% | EC |
| 45 | Tarsus Pharmaceuticals Inc | TARS | Mar 2026 | 1,487 | $104K | 0.49% | EC |
| 46 | Ultragenyx Pharmaceuticals Inc | RARE | Mar 2026 | 4,765 | $100K | 0.47% | EC |
| 47 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | Mar 2026 | 4,107 | $97K | 0.45% | EC |
| 48 | Axsome Therapeutics Inc. | AXSM | Mar 2026 | 566 | $96K | 0.45% | EC |
| 49 | GeneDx Holdings Corp | WGS | Mar 2026 | 1,409 | $90K | 0.42% | EC |
| 50 | Rhythm Pharmaceuticals Inc | RYTM | Mar 2026 | 974 | $85K | 0.39% | EC |
| 51 | HINGE HEALTH INC | HNGE | Mar 2026 | 2,182 | $84K | 0.39% | EC |
| 52 | Bristol-Myers Squibb Company | BMY | Mar 2026 | 1,111 | $67K | 0.31% | EC |
| 53 | Bio-Rad Laboratories, Inc. | BIO | Mar 2026 | 226 | $63K | 0.29% | EC |
| 54 | BEONE MEDICINES LTD | ONC | Mar 2026 | 209 | $62K | 0.29% | EC |
| 55 | TransMedics Group Inc. | TMDX | Mar 2026 | 482 | $48K | 0.22% | EC |
| 56 | Neurogene Inc. | NGNE | Mar 2026 | 1,840 | $37K | 0.17% | EC |
| 57 | Wave Life Sciences Ltd. | WVE | Mar 2026 | 4,470 | $32K | 0.15% | EC |
| 58 | Recursion Pharmaceuticals Inc | RXRX | Mar 2026 | 10,393 | $32K | 0.15% | EC |
| 59 | Caris Life Sciences Inc. | CAI | Mar 2026 | 557 | $10K | 0.05% | EC |
| 60 | OMNIAB INC | 2200963D | Mar 2026 | 240 | $0 | 0.00% | EC |
| 61 | OMNIAB INC | 2200964D | Mar 2026 | 240 | $0 | 0.00% | EC |